This inventor holds 2 USPTO granted patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Di Zhu: Innovator in Cancer Treatment
Introduction
Di Zhu is a prominent inventor based in Newton, MA (US). He has made significant contributions to the field of cancer treatment, particularly in the area of multiple myeloma. With a total of 2 patents, his work focuses on developing methods and compositions that can improve patient outcomes.
Latest Patents
Di Zhu's latest patents include innovative methods for treating multiple myeloma. One of his patents, titled "Compositions and methods for treating multiple myeloma," provides methods for identifying therapeutic agents for treating this hematological malignancy. It also outlines ways to determine the prognosis of patients suffering from multiple myeloma. This invention is based on the discovery that an extracellular form of cyclophilin A binds to CD147 expressed on multiple myeloma cells. Another patent, "Compositions and methods for treating malignancies," shares similar methodologies and insights, further emphasizing the potential of cyclophilin A in cancer treatment.
Career Highlights
Di Zhu is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research and innovations. His work is crucial in the ongoing battle against cancer, particularly in developing targeted therapies for difficult-to-treat malignancies.
Collaborations
Di Zhu collaborates with various professionals in the field, including his coworker Ruben Carrasco. These partnerships enhance the research and development of effective cancer treatments.
Conclusion
Di Zhu's contributions to cancer treatment through his patents and research are invaluable. His innovative approaches hold promise for improving the prognosis and treatment of multiple myeloma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
